Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Gynecology

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 74 articles: HTML format

Single Articles

August 2008
1. PONNUSAMY MP , Singh AP, Jain M, Chakraborty S, et al
   MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells.
   Br J Cancer. 2008;99:520-6.
   PubMed     Related articles    Abstract available
   
   
   
2. MULHOLLAND HG , Murray LJ, Cardwell CR, Cantwell MM, et al
   Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis.
   Br J Cancer. 2008;99:434-41.
   PubMed     Related articles    Abstract available
   
   
   
3. BIGNOTTI E , Ravaggi A, Tassi RA, Calza S, et al
   Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas.
   Br J Cancer. 2008.
   PubMed     Related articles    Abstract available
   
   
   July 2008
4. GUTH U , Huang DJ, Schotzau A, Zanetti-Dallenbach R, et al
   Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer.
   Br J Cancer. 2008.
   PubMed     Related articles    Abstract available
   
   
   
5. DE GRAEFF P , Crijns AP, Ten Hoor KA, Klip HG, et al
   The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.
   Br J Cancer. 2008;99:341-9.
   PubMed     Related articles    Abstract available
   
   
   
6. ARMAROLI P , Gallo F, Bellomi A, Ciatto S, et al
   Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results?
   Br J Cancer. 2008;99:239-44.
   PubMed     Related articles    Abstract available
   
   
   
7. YEUNG BH , Wong KY, Lin MC, Wong CK, et al
   Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2.
   Br J Cancer. 2008;99:283-93.
   PubMed     Related articles    Abstract available
   
   
   
8. LUO J , Margolis KL, Adami HO, Lacroix A, et al
   Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States).
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. DIAZ M , Kim JJ, Albero G, de Sanjose S, et al
   Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. VET JN , de Boer MA, van den Akker BE, Siregar B, et al
    Prevalence of human papillomavirus in Indonesia: a population-based study in three regions.
    Br J Cancer. 2008;99:214-8.
    PubMed     Related articles    Abstract available
    
    
    June 2008
11. ANTONIOU AC , Cunningham AP, Peto J, Evans DG, et al
    The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
    Br J Cancer. 2008;98:2015.
    PubMed     Related articles   
    
    
    
12. O'BRIEN PM , Davies MJ, Scurry JP, Smith AN, et al
    The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro.
    Br J Cancer. 2008;98:1880.
    PubMed     Related articles   
    
    
    
13. LEUNG EL , Fraser M, Fiscus RR, Tsang BK, et al
    Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.
    Br J Cancer. 2008;98:1803-9.
    PubMed     Related articles    Abstract available
    
    
    
14. WERNLI KJ , Newcomb PA, Hampton JM, Trentham-Dietz A, et al
    Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity.
    Br J Cancer. 2008;98:1781-3.
    PubMed     Related articles    Abstract available
    
    
    
15. VASEY PA , Gore M, Wilson R, Rustin G, et al
    A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers.
    Br J Cancer. 2008;98:1774-80.
    PubMed     Related articles    Abstract available
    
    
    May 2008
16. FERRANDINA G , Petrillo M, Carbone A, Zannoni G, et al
    Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. ENGELSEN IB , Mannelqvist M, Stefansson IM, Carter SL, et al
    Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
    Br J Cancer. 2008;98:1662-9.
    PubMed     Related articles    Abstract available
    
    
    
18. CALCAGNO AM , Fostel JM, To KK, Salcido CD, et al
    Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes.
    Br J Cancer. 2008;98:1515-24.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    April 2008
19. LIM SL , Smith P, Syed N, Coens C, et al
    Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer.
    Br J Cancer. 2008;98:1452-6.
    PubMed     Related articles    Abstract available
    
    
    
20. SARGENT A , Bailey A, Almonte M, Turner A, et al
    Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
21. O'BRIEN PM , Davies MJ, Scurry JP, Smith AN, et al
    The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro.
    Br J Cancer. 2008;98:1085-93.
    PubMed     Related articles    Abstract available
    
    
    
22. LINDEMANN K , Vatten LJ, Ellstrom-Engh M, Eskild A, et al
    Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. WRIGHT JD , Doan T, McBride R, Jacobson JS, et al
    Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. CHAN JK , Fuh K, Shin JY, Cheung MK, et al
    The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. XUE F , Hilakivi-Clarke LA, Maxwell GL, Hankinson SE, et al
    Longitudinal study on birthweight and the incidence of endometrial cancer.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. ANTONIOU AC , Cunningham AP, Peto J, Evans DG, et al
    The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. AHMED N , Riley C, Quinn MA
    An immunohistochemical perspective of PPARbeta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. KONECNY GE , Venkatesan N, Yang G, Dering J, et al
    Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. INGEMANN-HANSEN O , Lidang M, Niemann I, Dinesen J, et al
    Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. GOTO T , Takano M, Hirata J, Tsuda H, et al
    The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
31. YANG X , Fraser M, Abedini MR, Bai T, et al
    Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt.
    Br J Cancer. 2008;98:803-8.
    PubMed     Related articles    Abstract available
    
    
    
32. HUANG YK , You SL, Yuan CC, Ke YM, et al
    Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. FRUSCIO R , Colombo N, Lissoni AA, Garbi A, et al
    A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
34. PEARCE CL , Wu AH, Gayther SA, Bale AE, et al
    Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis.
    Br J Cancer. 2008;98:282-288.
    PubMed     Related articles    Abstract available
    
    
    
35. ALAM SM , Fujimoto J, Jahan I, Sato E, et al
    Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. AKIL N , Kassab A, Yasmeen A, Darnel AD, et al
    Human breast cancer and sexual activities.
    Br J Cancer. 2008;98:508-9.
    PubMed     Related articles   
    
    
    
37. SUZUKI R , Rylander-Rudqvist T, Saji S, Bergkvist L, et al
    Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. BOSCH FX , Castellsague X, de Sanjose S
    HPV and cervical cancer: screening or vaccination?
    Br J Cancer. 2008;98:15-21.
    PubMed     Related articles    Abstract available
    
    
    
39. VAN DE NIEUWENHOF HP , Massuger LF, de Hullu JA, van Ham MA, et al
    Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003.
    Br J Cancer. 2008;98:165-7.
    PubMed     Related articles    Abstract available
    
    
    December 2007
40. THORPE H , Brown SR, Sainsbury JR, Perren TJ, et al
    Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: The ITS Study.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. GRANSTROM C , Sundquist J, Hemminki K
    Population attributable fractions for ovarian cancer in Swedish women by morphological type.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. KABAT GC , Miller AB, Jain M, Rohan TE, et al
    Dietary iron and haem iron intake and risk of endometrial cancer: a prospective cohort study.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
43. LACEY JV JR , Ioffe OB, Ronnett BM, Rush BB, et al
    Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. BLECHSCHMIDT K , Sassen S, Schmalfeldt B, Schuster T, et al
    The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. KRASNER CN , McMeekin DS, Chan S, Braly PS, et al
    A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. HOFFMEISTER M , Raum E, Winter J, Chang-Claude J, et al
    Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
47. YAMAMOTO E , Ino K, Miyoshi E, Shibata K, et al
    Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. HENKEN FE , Wilting SM, Overmeer RM, van Rietschoten JG, et al
    Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. NEDERGAARD BS , Ladekarl M, Thomsen HF, Nyengaard JR, et al
    Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer.
    Br J Cancer. 2007;97:1135-8.
    PubMed     Related articles    Abstract available
    
    
    
50. GAKIOPOULOU H , Korkolopoulou P, Levidou G, Thymara I, et al
    Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications.
    Br J Cancer. 2007;97:1124-34.
    PubMed     Related articles    Abstract available
    
    
    
51. STEEVENS J , Schouten LJ, Verhage BA, Goldbohm RA, et al
    Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. RAY-COQUARD I , Paraiso D, Guastalla JP, Leduc B, et al
    Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. KIM JJ , Andres-Beck B, Goldie SJ
    The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. LUCENTEFORTE E , Bosetti C, Talamini R, Montella M, et al
    Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension.
    Br J Cancer. 2007;97:995-998.
    PubMed     Related articles    Abstract available
    
    
    September 2007
55. AMANT F , De Knijf A, Van Calster B, Leunen K, et al
    Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. SATOH T , Oki A, Uno K, Sakurai M, et al
    High incidence of silent venous thromboembolism before treatment in ovarian cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. OTA T , Takeshima N, Tabata T, Hasumi K, et al
    Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. CHANUDET E , Adam P, Nicholson AG, Wotherspoon AC, et al
    Chlamydiae and Mycoplasma infections in pulmonary MALT lymphoma.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. PIETERSE AH , Stiggelbout AM, Baas-Thijssen MC, van de Velde CJ, et al
    Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences.
    Br J Cancer. 2007;97:717-24.
    PubMed     Related articles    Abstract available
    
    
    
60. WYNNE P , Newton C, Ledermann JA, Olaitan A, et al
    Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
61. SCHUZ J , Martinussen N, Lightfoot T, Roman E, et al
    Molar pregnancy and childhood cancer: a population-based linkage study from Denmark.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. TROISI R , Innes KE, Roberts JM, Hoover RN, et al
    Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role?
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. MARLOW LA , Waller J, Wardle J
    Public awareness that HPV is a risk factor for cervical cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
64. CHAN JK , Kapp DS, Cheung MK, Osann K, et al
    The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. MINAS V , Rolaki A, Kalantaridou SN, Sidiropoulos J, et al
    Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. ANDERSEN TT , Georgekutty J, Defreest LA, Amaratunga G, et al
    An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. AGUAYO F , Castillo A, Koriyama C, Higashi M, et al
    Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile.
    Br J Cancer. 2007;97:85-91.
    PubMed     Related articles    Abstract available
    
    
    June 2007
68. LIU J , Harada H, Ogura M, Shibata T, et al
    Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts.
    Br J Cancer. 2007;96:1871-8.
    PubMed     Related articles    Abstract available
    
    
    May 2007
69. HERMSEN BB , Olivier RI, Verheijen RH, van Beurden M, et al
    No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
    Br J Cancer. 2007;96:1335-42.
    PubMed     Related articles    Abstract available
    
    
    
70. BRINTON LA , Sakoda LC, Lissowska J, Sherman ME, et al
    Reproductive risk factors for endometrial cancer among Polish women.
    Br J Cancer. 2007;96:1450-6.
    PubMed     Related articles    Abstract available
    
    
    March 2007
71. ALBREKTSEN G , Heuch I, Thoresen S, Kvale G, et al
    Twin births, sex of children and maternal risk of ovarian cancer: a cohort study in Norway.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. STANLEY M
    Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. BULKMANS NW , Berkhof J, Bulk S, Bleeker MC, et al
    High-risk HPV type-specific clearance rates in cervical screening.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
74. CHEN CL , Hsieh FC, Lieblein JC, Brown J, et al
    Stat3 activation in human endometrial and cervical cancers.
    Br J Cancer. 2007;96:591-9.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: